Teknova to Participate in Upcoming Investor Conference
May 25, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and...
Teknova Reports First Quarter 2023 Financial Results
May 10, 2023 16:01 ET
|
Alpha Teknova, Inc.
First quarter 2023 total revenue was $9.1 million, up 16% sequentially Launch of proprietary AAV-Tek™ Solutions gene therapy product line Company reaffirms 2023 revenue guidance of $42-46 million ...
Teknova to Present Data on Novel Products to Accelerate the Development of AAV Therapies at ASGCT 2023 Annual Meeting
May 10, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and...
Teknova Announces Time Change for First Quarter 2023 Financial Results Conference Call on May 10, 2023
May 04, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and...
Teknova Launches Proprietary AAV-Tek™ Solutions Gene Therapy Product Line to Accelerate the Development of AAV Therapies
May 02, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and...
Teknova to Report First Quarter 2023 Financial Results on May 10, 2023
April 26, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and...
Teknova Reports Fourth Quarter and Full Year 2022 Financial Results
March 15, 2023 16:01 ET
|
Alpha Teknova, Inc.
Full year 2022 total revenue was $41.4 million, up 12% year-over-yearNew, state-of-the-art manufacturing facility now operationalCompany provides 2023 revenue guidance of $42-46 million HOLLISTER,...
Teknova and Sartorius BIA Separations Announce Collaboration to Address Critical Pain Point in Gene Therapy Process Development
March 15, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), and Sartorius BIA Separations, which is part of the international life science group Sartorius,...
Teknova to Report Fourth Quarter and Full Year 2022 Financial Results on March 15, 2023
February 23, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and...
Teknova to Participate in Upcoming Investor Conferences
February 10, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and...